HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A review of sodium oxybate and baclofen in the treatment of sleep disorders.

Abstract
Studies examining GABA(B) receptor agonists have reported effects on sleep including decreased sleep onset latency (SOL), increased sleep consolidation and increases in slow wave sleep (SWS). γ-hydroxybutyrate (GHB) is proposed to act as a GABA(B) receptor agonist; however, the mechanism of action of GHB is controversial. In addition, the GABA(B) receptor agonist, baclofen, has also been proposed to exert similar effects on sleep. The aim of this paper is to provide a review of the human clinical studies of sodium oxybate and baclofen regarding sleep and the treatment of sleep disorders including narcolepsy and insomnia, as well as other disorders involving disrupted sleep such as fibromyalgia.
AuthorsMark A Brown, Christian Guilleminault
JournalCurrent pharmaceutical design (Curr Pharm Des) Vol. 17 Issue 15 Pg. 1430-5 ( 2011) ISSN: 1873-4286 [Electronic] United Arab Emirates
PMID21476957 (Publication Type: Journal Article, Review)
Chemical References
  • GABA-B Receptor Agonists
  • Sodium Oxybate
  • Baclofen
Topics
  • Animals
  • Baclofen (pharmacology, therapeutic use)
  • GABA-B Receptor Agonists (pharmacology, therapeutic use)
  • Humans
  • Narcolepsy (drug therapy, metabolism)
  • Sleep (drug effects)
  • Sleep Initiation and Maintenance Disorders (drug therapy, metabolism)
  • Sleep Wake Disorders (drug therapy, metabolism)
  • Sodium Oxybate (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: